Introduction
Two enzymes are directly responsible for dAdo concentration in the cell: dAdoK and ADA. Inher ited deficiency of ADA activity in acute lympho blastic leukemia [1] is associated with high levels of deoxyribonucleoside phosphorylating activity, and low levels of deoxyribonucleotide dephosphorylating activity, as well as with toxic concen tration of dATP and immunological disfunction [2, 3] , On the contrary, ADA inhibited normal hu man peripheral blood lymphocytes excreted dAdo and the peak of dAdo excretion is concomitant with the maximal incorporation of dThd into DNA [4] , Although the mechanism of dAdo toxi city is still unresolved, the inhibition of ribonu cleotide reductase by dATP and S-adenosylhomocysteine hydrolase by dAdo have been pro posed as its important effects [5] . Basing on these data we have undertaken a study of nucleoside and nucleotide influence on partially purified dAdoK Abbreviations: dA doK , deoxyadenosine kinase; A D A , adenosine deaminase; dThd, 2'-deoxythymidine; dAdo, 2'-deoxyadenosine; dG uo, 2'-deoxyguanosine; dlno, 
Materials and Methods

Chemicals
U 14C Ado and dAdo were obtained from Amersham Corp. (England). Unlabelled ribo-and 2'-deoxyribonucleosides and their 5'-mono-, diand triphosphates were purchased from Sigma Chemical Company (U.S.A.) and from Calbiochem-Behring Corp. (U.S.A.). Other reagents used were highest quality commercial products of Phar macia Fine Chemicals, Whatman, Fluka AG Loba Chemie (Wien), Koch-Light Lab and POCh (Poland).
Enzyme assays
Enzyme activity was measured under optimal conditions at linear kinetics. dAdoK assay was performed as described earlier [6] . For ADA activ ity assay, the incubation mixture of 0.5 ml final volume contained (in final concentration) 80 m M T ris[(hydroxymethyl)aminomethane]-HCl buffer (pH 8.0), 1 m M Ado/dAdo (0.05 |iCi per sample) and purified enzyme (30-40 \xg per sample). After incubation at 37 °C for 40 min, the reaction was stopped by immersion of the tubes for 2 min in boiling water and 100 p.1 of the supernatant ob-tained after removal of denatured protein was spotted on Whatman DE 81 chromatography pa per. Ado or dAdo were separated from Ino or dlno in 2 m M ammonium formate (with Rf for Ado, dAdo, Ino and dlno of 0.58, 0.27, 0.24 and 0.08, respectively), and spots corresponding to standards were counted in an LKB liquid scintilla tion counter. Km values were calculated from eight substrate concentrations using equations de scribed in [6] , K{ values were calculated according the same method after the kind of inhibition had been determined (each value of Km and K;. the mean ± S.D. for four experiments).
Enzyme preparation
dAdoK purification was performed as described previously [7] , Partially purified ADA was ob tained according to Tsukada and Yoshino method [8] with our own modifications as follows: mito chondria from livers of 15 female Wistar rats, iso lated as described in [7] were suspended for 8 h in 25 m M Tris-HCl buffer (pH 7.4) containing 25 m M KC1 and 5 m M MgCl2 (buffer A) and sonicated (MSE ultrasonic disintegrator). Disrupted mito chondria were centrifuged (105000 x g for 60 min) and the supernatant was heated at 65° for 8 min. The precipitate was discarded (15000 x g for 40 min) and CaCl2 (to the final concentration of 3 m M ) and (NH4)2S 0 4 (to give 65% saturation) were added to the supernatant. The precipitate was removed by centrifugation (15000 x g for 40 min), dissolved in 50 m M borate buffer (pH 7.6), con taining 2 m M CaCl2 (buffer B) and dialyzed over night against buffer B. Dialyzed solution was ap plied to DEAE cellulose column (0.9 x 30 cm) and the protein was eluted from the column with linear gradient of NaCl (from 0.12 m to 0.4 m ) in buffer B. The fractions with ADA activity, concentrated by dialysis against Ficoll, were then transferred to Sephadex G-150 column (2.5 x40 cm). The pro tein was eluted by buffer B containing 0.15 m NaCl and fractions with ADA activity were concentrat ed as above. The cytosol ADA obtained from 10% (v/w) liver homogenate in buffer A, as a result of postmitochondrial supernatant centrifugation (105000 x g for 60 min) was prepared under the same conditions. Polyacrylamide gel electropho resis, gel isoelectric focusing and molecular weight determination by gel filtration in Sephadex G-150 were carried out as described previously [7] , Pro tein concentrations were determined as in [9] , with bovine serum albumin as standard.
Results and Discussion
dAdoK from mitochondria and cytosol was purified 932-fold and 290-fold, respectively; ADA from the mentioned subcellular fractions was puri fied 927-fold and 1022-fold. The apparent molecu lar weight of dAdoK was estimated to be 40 kDa for mitochondrial enzyme and 78 kDa for the cyto sol enzyme. ADA from both mitochondria and cy tosol have mol wt. of 34 kDa. pi values were found to be 6.7 ± 0.2 and 7.7 ± 0.3 for mitochondrial and cytosol dAdoK, respectively, and 5.2 ± 0.2 for mi tochondrial and cytosol ADA. dAdoK and ADA showed Michaelis-Menten kinetics. Km of mito chondrial and cytosol dAdoK were obtained at 8.5 ± 1.8 } im and 750 ± 167 | i m , respectively, and at 30.8 ±6.0 h m and 28.7 ± 5.8 | i m for, correspond ingly, mitochondrial and cytosol ADA (using dAdo as substrate).
Influence of nucleosides and nucleotides on both mitochondrial and cytosol enzymes and char acter of changes of dAMP synthesis and dAdo deamination in presence of dGTP, are presented in Table I and Fig. 1 . Using the compounds indicated, only dGTP modified dAdo metabolism in mito chondria and cytosol, however the influence of dGTP on dAdo phosphorylation and dAdo deami nation is quite different. In mitochondria dGTP strongly competitively inhibits dAMP synthesis (Kmi/Km = 502, reduction of dAdo phosphoryla tion by 97.5%, Fig. 1 a, a,, Table I ), and activates dAdo deamination (activation of dAdo deaminase activity by 44% (Fig. lc, Table I ). In cytosol, on the contrary, dGTP activates dAdo phosphoryla tion by 57% (Fig. lb , Table I ) and inhibits dAdo deamination by mixed inhibition (reduction of dAdo deamination by 64%, Fig. Id, Table I ). Ac tivating effect of dGTP on dAdo deamination in mitochondria is probably connected with changes of conformation of the catalytic centre of ADA, without a similar effect of dAMP synthesis in cyto sol (different Km value in presence of dGTP for mi tochondrial dAdo deaminase, Fig. lc ; lack of changes of Km value with dGTP for cytosol dAdo kinase, Fig. 1 b) .
The cells either utilize the anabolic way of phosphorylating dAdo or reduce the concentration of phorylated to dAdo which, in turn, is deaminated to dlno by ADA [13] . It helps to understand a dif ferent effect of dGTP upon deoxyadenosine phos phate synthesis in mitochondria and cytosol. In mitochondria dGTP prefers catabolism of dAdo by simultaneously activating ADA and inhibiting dAdo kinase. In cytosol, on the other hand, dGTP privileges dAdo anabolism by activating dAMP synthesis and decreasing dAdo deamination ( Fig. 1 b, d , Table I ). In case of dGTP deficiency in mitochondria, the synthesis of dATP is elevated, which by activating dGuo kinase [14] and increas ing dGTP concentration restores the relation showed in Fig. 2 . It is a possible protective mecha nism of mitochondria against the effects of toxic dATP accumulation. dGTP deficiency in cytosol changes both -activation of dAMP synthesis and inhibition of dAdo deamination to a comparable extent (Fig. 2, Table I ). It prompts suggestions that dlno synthesis privilege is one of the mecha nisms by which the changes of dGTP concentra tions in cytosol are used in the regulation of toxic dATP concentration. The analysis of mechanisms, controlling the accumulation of toxic dAdo and dATP in mitochondria and cytosol and connected with changes of dGTP concentrations, should also dAdo in a catabolic process in which ADA is the main enzyme [10, 11] to protect themselves against the accumulation of toxic dAdo [12] . Beside dAMP synthesis following dAdo phosphorylation, dAMP formed during dATP catabolism is dephos-comprise the fact that dAMP synthesis is sup pressed by dATP by a feedback inhibition (Fig. 2 , Table I ). Quantitatively the effect is similar both in mitochondria and cytosol (A^mimit/A^micyt = 0.64, Table I ). However, it concerns mainly cytosol, where dGTP activates dAMP synthesis and not mitochondria, where dGTP increases dAdo deam ination (Fig. 1 b, c) .
It is striking that mitochondrial and cytosol ADA, having the same physical properties, behave completely differently in the presence of dGTP.
